Ali Rismani
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 16
- Multiple Myeloma Research and Treatments 12
- Blood groups and transfusion 3
- Genetics 14
- Chronic Lymphocytic Leukemia Research 11
- Co-authors
- Shirley D’Sa (23 shared papers)Kwee Yong (13 shared papers)Rakesh Popat (10 shared papers)Neil Rabin (10 shared papers)Arash Latifoltojar (3 shared papers)Νικόλαος Δικαίος (3 shared papers)Magdalena Sokolska (3 shared papers)Margaret Hall‐Craggs (3 shared papers)
- Journals
- Blood (13 papers)British Journal of Haematology (5 papers)British Journal of Cancer (1 paper)HemaSphere (1 paper)European Radiology (1 paper)
- Partner nations
- United KingdomNetherlandsCanada
In The Last Decade
Ali Rismani
23 papers receiving 220 citations
Peers
Comparison fields: 5 of 41
- Hematology 134
- Genetics 56
- Oncology 93
- Orthopedics and Sports Medicine 20
- Emergency Medicine 21
Countries citing papers authored by Ali Rismani
This map shows the geographic impact of Ali Rismani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Rismani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Rismani more than expected).
Fields of papers citing papers by Ali Rismani
This network shows the impact of papers produced by Ali Rismani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Rismani. The network helps show where Ali Rismani may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Rismani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 59 | |
| 2 | 2016 | 46 | |
| 3 | 2020 | 42 | |
| 4 | 2017 | 21 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 8 | |
| 7 | 2016 | 7 | |
| 8 | 2022 | 5 | |
| 9 | 2024 | 3 | |
| 10 | 2020 | 3 | |
| 11 | 2015 | 3 | |
| 12 | 2021 | 2 | |
| 13 | 2022 | 2 | |
| 14 | 2016 | 2 | |
| 15 | 2018 | 2 | |
| 16 | 2018 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2016 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2020 | 1 |
About Ali Rismani
Ali Rismani is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Pathology and Forensic Medicine, having authored 25 papers that have together received 222 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (6 papers), Cancer Treatment and Pharmacology (5 papers), Protein Degradation and Inhibitors (5 papers), Blood groups and transfusion (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Bone health and treatments (2 papers). The work is most often cited by research in Hematology (134 citations), Genetics (56 citations), Oncology (93 citations), Orthopedics and Sports Medicine (20 citations) and Emergency Medicine (21 citations). Ali Rismani has collaborated with scholars based in United Kingdom, Netherlands and Canada. Frequent co-authors include Shirley D’Sa, Kwee Yong, Rakesh Popat, Neil Rabin, Arash Latifoltojar, Νικόλαος Δικαίος, Magdalena Sokolska, Margaret Hall‐Craggs, Charalampia Kyriakou and Sébastien Ourselin. Their work appears in journals such as Blood, British Journal of Haematology, British Journal of Cancer, HemaSphere and European Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.